CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-09 | FENNELL GEORGE Executive Vice President | Option exercise | +1,476 | $67.85 | $100K | 9,823 |
| 2026-02-09 | FENNELL GEORGE Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −1,476 | 0 | ||
| 2026-01-30 | HOOLEY JOSEPH L Director | Grant or award | +36 | $670.46 | $24K | 75 |
| 2025-12-01 | Peacock Karen Director | Grant or award · Restricted Stock Unit | +101 | 101 | ||
| 2025-12-01 | Peacock Karen Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +231 | 231 | ||
| 2025-11-07 | Hunt Nimrata Executive Vice President | Option exercise | +7,125 | $288.78 | $2.1M | 25,168.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Option exercise | +5,405 | $505.53 | $2.7M | 30,573.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Sale | −5,114 | $702.20 | $3.6M | 25,459.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Sale | −1,465 | $703.73 | $1.0M | 23,994.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Sale | −1,468 | $704.87 | $1.0M | 22,526.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Sale | −1,378 | $705.54 | $972K | 21,148.94 |
| 2025-11-07 | Hunt Nimrata Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −7,125 | 0 | ||
| 2025-11-07 | Hunt Nimrata Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −5,405 | 1,604 | ||
| 2025-10-30 | HOOLEY JOSEPH L Director | Grant or award | +39 | $628.54 | $25K | 39 |
| 2025-09-01 | Smith Martin Alexander Executive Vice President | Option exercise | +18 | 1,438.66 | ||
| 2025-09-01 | Smith Martin Alexander Executive Vice President | Shares withheld for taxes | −5 | $647.09 | $3K | 1,433.66 |
| 2025-09-01 | Smith Martin Alexander Executive Vice President | Option exercise · Restricted Stock Unit | −18 | 0 | ||
| 2025-09-01 | HOOLEY JOSEPH L Director | Grant or award · Restricted Stock Unit | +158 | 158 | ||
| 2025-09-01 | HOOLEY JOSEPH L Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +364 | 364 | ||
| 2025-08-22 | SZOSTAK M ANNE Director | Option exercise | +2,187 | $206.62 | $452K | 2,449 |
Page 14 of 52 · 1,036 trades